SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-025099
Filing Date
2022-09-06
Accepted
2022-09-06 13:15:56
Documents
9
Period of Report
2022-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 41594
2 ex1-1.htm EX-1.1 398730
3 ex4-1.htm EX-4.1 147985
4 ex4-2.htm EX-4.2 151533
5 ex4-3.htm EX-4.3 258294
6 ex99-1.htm EX-99.1 13339
7 ex99-2.htm EX-99.2 19798
8 ex99-1_001.jpg GRAPHIC 6177
9 ex99-2_001.jpg GRAPHIC 11148
  Complete submission text file 0001493152-22-025099.txt   1056582
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

IRS No.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 221227785
SIC: 8731 Services-Commercial Physical & Biological Research